US 9855226
d-methadone for the treatment of psychiatric symptoms
granted A61KA61K31/137A61K45/06
Quick answer
US patent 9855226 (d-methadone for the treatment of psychiatric symptoms) held by Relmada Therapeutics, Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relmada Therapeutics, Inc.
- Grant date
- Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/137, A61K45/06, A61K9/0019, A61P